Replies to post #12362 on Innovus Pharmaceuticals Inc. (fka INNV)

[ShawnP123]

OK Rebel, let's be a little more specific.

After the Reverse split (1 share for 15) during Nexmed the stock was at approximately $34.00. You are correct when you stated the stock went up to $56.00. However, Damaj started diluting the stock and when he left, the stock was at $30.00.

He was CEO of Apricus for about 2.5 yrs before he left.

Let's do a comparison between INNV and Apricus.

He became CEO of INNV in Jan of 2013. Stock price was approx. 0.60. In Sept. of 2013 it hit a high of 0.95 which was approx. 37% increase. Since then we have seen an erosion of the stock price. Just prior to significant price erosion the stock hit a high of around 0.65. Then came the major dilutions and here we are.

Apricus- After Nexmed stock split SP was approx $34.00. In September it hit a high of $56.00 what translates into a 39% increase. Then the dilutions started and the stock dropped to approx $30.00 before he left and was going down fast.

If you find something wrong in my comparison, please let me know.

Similar percentages.